Chronic obstructive pulmonary disease (COPD) is characterised by airflow limitation that is usually progressive, and is associated with an enhanced chronic inflammatory response to noxious particles or gases in the airways and lungs. Exacerbations and comorbidities contribute to the overall severity of the condition in individual patients.
(1)
HOW COMMON IS THIS IN MY PRACTICE?
COPD is the fourth leading cause of death in the world and a major cause of chronic morbidity. The disease is also among the top seven causes of hospitalisation and death in Singapore in 2011; the prevalence rates of moderate to severe COPD in Singapore is estimated at 3.5%. 
WHAT CAN I DO IN MY PRACTICE?
Making an early diagnosis COPD is a preventable and treatable disease. Early diagnosis and appropriate treatment may improve symptoms, reduce the rate and severity of exacerbations, improve quality of life and exercise capacity, and prolong survival in patients. (3) Patients in early stages of COPD may have undetected activity limitations, such as walking slower than their peers or experiencing difficulties in performing activities that could easily be completed previously; such limitations may lead to lifestyle changes and deconditioning. (4) Hence, early diagnosis is critical in preventing worsening of COPD and reducing the burden of symptoms.
Clinical features of COPD
Clinical features of COPD include: (a) progressive dyspnoea, which typically worsens with exercise; (b) chronic cough, which may or may not be productive; and (c) risk factors such as passive or active smoking and family history of COPD. The more severe form of COPD is associated with weight loss, anorexia, depression, coronary heart disease, lung cancer and cognitive dysfunction. Physical examination typically reveals a prolonged expiratory phase in mild cases of COPD and features of hyperinflation as the severity of airway obstruction increases. Spirometry usually shows obstruction (forced expiratory volume in 1 second/forced vital capacity [FEV1/FVC] < 0.7) and no bronchodilator response.
Misdiagnosis of COPD
It is challenging to diagnose COPD, especially with mimickers such as asthma; a study has shown that primary care physicians have difficulties in correctly classifying up to 19.8% of patients. (5) Differentiating between asthma and COPD is important, as the treatment algorithms, choices and objectives differ in each condition. (6) In persistent asthma, inhaled steroids are the basis of treatment, while in COPD, bronchodilators are the mainstay of treatment, with inhaled steroids only recommended in patients with severe COPD. (1, 7, 8) However, steroid therapy may come with adverse effects; for instance, a study has shown that there is a higher risk of pneumonia in patients with COPD treated via inhaled steroids. (9) Misdiagnosis of COPD as pulmonary tuberculosis will similarly lead to a lack of appropriate treatment, resulting in a progression of the disease in the individual and further spread in the community. As such, correct diagnosis is pertinent, as misdiagnosis will lead to inappropriate treatment and suboptimal patient outcomes. 
COPD vs. differential diagnosis
Differential diagnoses for COPD include asthma, obesity-related respiratory disease, ischaemic heart disease, congestive heart failure, bronchiectasis and tuberculosis. Table I shows the suggestive features of the aforementioned conditions, which will help in differentiating these diagnoses based on clinical presentations. cessation counselling sessions (3 minutes) have been shown to be effective, with cessation rates of 5%-10% reported. (1, 11) The "5As" -Ask, Advise, Assess, Assist and Arrange -can be employed to help patients who are willing to quit. Counselling by physicians is also found to significantly increase quit rates as compared to self-initiated strategies. (1, 12) The Singapore Health Promotion Board QuitLine offers advice and useful information on how to quit smoking.
Management of mild COPD
Annual influenza vaccination has been reported to significantly reduce COPD exacerbations.
(1,13) Nichol et al found that pneumococcal vaccination for elderly patients with chronic lung disease reduces mortality and hospitalisations for pneumonia, and has direct medical care cost savings. (14) Patients with COPD can also benefit from rehabilitation and physical activity maintenance, as they improve exercise capacity, minimise hospitalisation and mortality rates, and improve recovery after exacerbation and quality of life. (1, 15) Pulmonary rehabilitation is currently organised in local hospitals. Preliminary evidence shows that yoga training may improve lung function and exercise capacity on a short-term basis. (16, 17) However, further studies are needed to substantiate these positive effects of yoga in COPD patients.
Mild COPD can also be managed by pharmacotherapy. Bronchodilator therapy is central to symptom management in patients with COPD and should be maximised before inhaled steroids are considered. An aerochamber can be used in cases where patient inhaler technique is incompetent. Bronchodilators can be prescribed pro re nata or on regular basis to reduce symptoms. Examples of bronchodilators include beta2-adrenoceptor agonist (short-or long-acting beta2-adrenoceptor agonists [SABA or LABA]), antimuscarinic agent and methylxanthines. Combination therapy (SABA + antimuscarinic agent) produces more sustained effects with fewer side effects compared to increasing doses of single bronchodilators. Long-term treatment with inhaled corticosteroids (ICS) is only recommended in patients with severe COPD and frequent exacerbations that cannot be controlled using LABA. Combination therapy (LABA + ICS) is more effective than the respective individual drugs. Oral mucolytic agents may reduce the risk of COPD exacerbation in patients receiving little or no treatment. (18) It is important to monitor the disease progression and development of complications such as pneumonia, pneumothorax, bronchiectasis and right heart failure, as well as screen for and manage any comorbidities associated with COPD, such as common cardiovascular and metabolic diseases, anxiety/ depression and osteoporosis. The attending physician should be 
COMMON PITFALLS IN DIAGNOSING COPD
Referral to a specialist is recommended when there is progression of the disease or uncertainty regarding the diagnosis. Table II lists the various scenarios for which patients with COPD should be referred to a specialist. (19) TAKE HOME MESSAGES ABSTRACT Chronic obstructive pulmonary disease (COPD) is a condition commonly encountered by primary care practitioners. The disease should be detected in its early stages to prevent disease progression and to reduce the burden of symptoms. Early treatment also results in improved mortality and reduced morbidity. COPD should be differentiated from other similar conditions such as asthma, as the basis of treatment differs in these conditions, and misdiagnosis can lead to poorer patient outcomes. Non-pharmacological treatment such as smoking cessation and vaccinations are important in the management of COPD, while pharmacotherapy such as bronchodilators and antimuscarinics are the mainstay of therapy in COPD. Referral to a specialist is recommended when there is progression of the disease or uncertainty regarding the diagnosis.
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True False
Chronic obstructive pulmonary disease (COPD) is characterised by airflow limitation that is usually progressive, and is associated with an enhanced chronic inflammatory response to noxious particles or gases in the airways and lungs. 2. COPD is not among the top five leading causes of death in the world, or the top ten causes of hospitalisation and death in Singapore in 2011. 3. Early diagnosis and appropriate treatment can help patients to improve symptoms, reduce the rate and severity of exacerbations, improve quality of life and exercise capacity, and prolong survival. 4. Patients with early COPD may walk slower than their peers, or face difficulties performing activities that could easily be done previously, and such problems can lead to changes in lifestyle and deconditioning. 5. Other differential diagnoses should be considered if a patient classified as having COPD consistently experience progressive dyspnoea, which typically worsens with exercise; chronic cough, which may or may not be productive; and have risk factors such as passive or active smoking. 6. The typical clinical symptoms of progression of COPD do not include weight loss, anorexia, depression and coronary heart disease. 7. Physical examination that reveals a prolonged expiratory phase and hyperinflation is consistent with airway obstruction. 8. In patients with COPD, spirometry typically shows obstruction (FEV1/FVC < 0.7) and insignificant bronchodilator response. 9. A study found that the diagnosis of COPD can be incorrectly classified in up to a fifth of patients in primary care. 10. There is no practical implication in accurately classifying patients as having asthma or COPD, as their treatment algorithms (both steroids and beta-agonists inhalers) and lifestyle management are the same. 11. In persistent asthma, inhaled steroids are the basis of treatment, while bronchodilators are the mainstay of treatment in COPD. 12. Only patients with severe COPD may benefit from inhaled steroids. 13. The routine use of inhaled steroid therapy in the treatment of COPD may increase the risk of pneumonia in such patients. 14. Misdiagnosis of COPD as pulmonary tuberculosis will lead to further progression of the disease in the individual and spread of COPD in the community. 15. Differentials for COPD include asthma, obesity-related respiratory disease, ischaemic heart disease, congestive heart failure, bronchiectasis and tuberculosis. 16. Brief smoking cessation counselling by the physician is effective, but delivers a modest 1%-3% cessation rates. 17. A single dose of influenza and pneumococcal vaccine each is the current recommendation for treatment of patients aged > 65 years with COPD. 18. Pulmonary rehabilitation or incorporation of regular physical activity is important, as it helps to reduce hospital admissions and mortality in patients with COPD. 19. Early detection and management of COPD progression and complications such as pneumonia, pneumothorax, bronchiectasis and right heart failure is important. 20. Short courses of antibiotics in moderate, infective exacerbations of COPD may be considered when there is heightened breathlessness with increased sputum volume and purulence. SINGAPORE MEDICAL COUNCIL CATEGORY 3B CME PROGRAMME (Code SMJ 201504A) 
